Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Medulloblastoma is the most common malignant brain tumor in children. It has WNT-driven, SHH-driven/
TP53
mutant, SHH-driven/
TP53
wildtype, and non-WNT/non-SHH subgroups. MAGMAS (Mitochondrial Associated Granulocyte Macrophage colony-stimulating factor Signaling molecules) encodes a mitochondrial import inner membrane translocase subun...
Alternative Titles
Full title
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_3119602746
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3119602746
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0300411
